It is therefore pivotal to confirm these findings in a prospective study and investigate TP53 mutation status in routine clinical practice for cases of MYC translocation positive DLBCL, in addition to the current standard investigation for BCL2 translocation. Here, TP53 is linked to diffuse large B-cell lymphoma.